These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4351589)

  • 21. Continuous naloxone infusion in pediatric narcotic overdose.
    Lewis JM; Klein-Schwartz W; Benson BE; Oderda GM; Takai S
    Am J Dis Child; 1984 Oct; 138(10):944-6. PubMed ID: 6475855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of drug overdosage with naloxone, a specific narcotic antagonist.
    Evans LE; Swainson CP; Roscoe P; Prescott LF
    Lancet; 1973 Mar; 1(7801):452-5. PubMed ID: 4120366
    [No Abstract]   [Full Text] [Related]  

  • 23. Naloxone.
    Martin WR
    Ann Intern Med; 1976 Dec; 85(6):765-8. PubMed ID: 187095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 25. The oral absorption of methadone from a new parenterally nonabusable tablet.
    Van Harken DR; Monteleone P; Caruso FS; Bloom WA
    Proc Natl Conf Methadone Treat; 1973; 2():1355-61. PubMed ID: 4808288
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism and pharmacokinetics of naloxone.
    Weinstein SH; Pfeffer M; Schor JM
    Adv Biochem Psychopharmacol; 1973; 8(0):525-35. PubMed ID: 4794980
    [No Abstract]   [Full Text] [Related]  

  • 27. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 28. Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose.
    Goldberg SA; Dworkis DA; Liao VT; Eyre AJ; Albert J; Fawcett MM; Narovec CM; DiClemente J; Weiner SG
    Prehosp Emerg Care; 2018; 22(6):788-794. PubMed ID: 29723076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial of naloxone imperative in children with unexplained reduced consciousness level.
    Arch Dis Child; 2008 Feb; 93(2):183. PubMed ID: 18209001
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 31. Group covert sensitization with narcotic addicts (further comments).
    Steinfeld GJ; Rautio EA; Rice AH; Egan MJ
    Int J Addict; 1974; 9(3):447-64. PubMed ID: 4443138
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort.
    Kobayashi L; Green TC; Bowman SE; Ray MC; McKenzie MS; Rich JD
    Simul Healthc; 2017 Feb; 12(1):22-27. PubMed ID: 28146450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rating the presence and severity of opiate dependence.
    Wang RI; Wiesen RL; Lamid S; Roh BL
    Clin Pharmacol Ther; 1974 Oct; 16(4):653-8. PubMed ID: 4422361
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acute narcotic poisoning with naloxone. 12 cases].
    Commin P; Bismuth C; Raffaelli C
    Nouv Presse Med; 1977 Feb; 6(7):565. PubMed ID: 840638
    [No Abstract]   [Full Text] [Related]  

  • 35. Methadone maintenance and narcotic blocking drugs. Appendix.
    Wikler A
    Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero RM; Parran TV; Adelman CL; Piche B
    Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone hydrochloride: a review.
    Goodrich PM
    AANA J; 1990 Feb; 58(1):14-6. PubMed ID: 2180244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental analysis of conditioning factors in human narcotic addiction.
    O'Brien CP
    Pharmacol Rev; 1975 Dec; 27(4):533-43. PubMed ID: 1223916
    [No Abstract]   [Full Text] [Related]  

  • 39. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An interesting case of opium tea toxicity.
    Seyani C; Green P; Daniel L; Pegden A
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28455458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.